Toxic encephalopathy

Safety and Health at Work

Volumn 3, Issue 4, 2012, Pages 243-256

  Kim, Yangho ^a   Kim, Jae Woo ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Dong A University   (South Korea)

Author keywords

Nervous system diseases; Occupational diseases; Toxic encephalopathy

Indexed keywords

EID: 84879027910     PISSN: 20937911     EISSN: 20937997     Source Type: Journal    
DOI: 10.5491/SHAW.2012.3.4.243     Document Type: Review

References (125)

1. US Environmental Protection Agency. Toxic Substances Control Act (TSCA). Chemical substance inventory-revised inventory synonym and preferred name file. Washington, DC: Office of Pollution, Prevention, and Toxics; 2000.
2. Dobbs MR. Clinical neurotoxicology: Syndromes, substances, environments. 1st ed. Philadelphia (PA): Saunders; 2009. p. 3-6.
3. Dobbs MR. Toxic encephalopathy. Semin Neurol 2011;31: 184-93.
4. Firestone JA, Longstrength WT Jr. Neurologic and psychiatric disorders. In: Rosenstock L, Cullen M, Brodkin C, Redlich C, editors. Textbook of clinical occupational and environmental medicine. 4th ed. Philadelphia (PA): Saunders; 2004. p. 645-60.
5. Rosenberg NL. Recognition and evaluation of work-related neurologic disorders. In: Rosenberg NL, editor. Occupational and environmental neurology. Boston (MA): Butterworth-Heinemann; 1995. p. 9-45.
6. So YT. Neurotoxicology. In: Ladou J, editor. Current occupational and environmental medicine. 2nd ed. New York (NY): McGraw Hill; 2007. p. 373-83.
7. Levin SM, Lilis R. Carbon disulfide. In: Rom WN, Markowitz SB, editors. Environmental and occupational medicine. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2006. p. 1219-25.
8. Kim Y, Jeong KS, Yun YH, Oh MS. Occupational neurologic disorders in Korea. J Clin Neurol 2010;6:64-72.
9. Spencer PS. Biological principles of chemical neurotoxicity. In: Spencer PS, Schaumburg HH, Ludolph AC, editors. Experimental and clinical neurotoxicology. 2nd ed. Oxford: Oxford University Press; 2000. p. 3-54.
10. Schaumburg HH, Spencer PS. Recognizing neurotoxic disease. Neurology 1987;37:276-8.
11. World Health Organization (WHO), Nordic Council of Ministers. Chronic effects of organic solvents on the central nervous system and diagnostic criteria : report on a joint WHO/Nordic Council of Ministers Working Group; 1985 Jun 10-14; Copenhagen, Denmark. Copenhagen: WHO, Regional Office for Europe, Nordic Council of Ministers; 1985.
12. Claudio L, Kwa WC, Russell AL, Wallinga D. Testing methods for developmental neurotoxicity of environmental chemicals. Toxicol Appl Pharmacol 2000;164:1-14.
13. Bates D. Diagnosis of neurotoxic syndromes. In: Blain PG, Harris JB, editors. Medical neurotoxicology. London (UK): Arnold; 1999. p. 3-11.
14. Nam B, Kim H, Choi Y, Lee H, Hong ES, Park JK, Lee KM, Kim Y. Neurologic sequela of hydrogen sulfide poisoning. Ind Health 2004;42:83-7.
15. Yoo CI, Kim Y, Jeong KS, Sim CS, Choy N, Kim J, Eum JB, Nakajima Y, Endo Y, Kim YJ. A case of acute organotin poisoning. J Occup Health 2007;49:305-10.
16. Dietemann JL, Botelho C, Nogueira T, Vargas MI, Audibert C, Abu Eid M, Bogorin A, Bernardo R, Jacques C, Kremer S, Zöllner G. Imaging in acute toxic encephalopathy. J Neuroradiol 2004;31:313-26.
17. Baker EL, Seppäläinen AM. Proceedings of the Workshop on neurobehavioral effects of solvents. October 13-16, 1985, Raleigh, North Carolina, U.S.A. Neurotoxicology 1986;7:1-95.
18. World Health Organization (WHO). The ICD 10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva (Switzerland): WHO; 1992.
19. American Psychiatric Association. Diagnostic and statistical manual for mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994
20. Keski-Säntti P, Mäntylä R, Lamminen A, Hyvärinen HK, Sainio M. Magnetic resonance imaging in occupational chronic solvent encephalopathy. Int Arch Occup Environ Health 2009;82:595-602.
21. van der Hoek JA, Verberk MM, Hageman G. Criteria for solvent-induced chronic toxic encephalopathy: a systematic review. Int Arch Occup Environ Health 2000;73:362-8.
22. Kaukiainen A, Akila R, Martikainen R, Sainio M. Symptom screening in detection of occupational solvent-related encephalopathy. Int Arch Occup Environ Health 2009;82:343-55.
23. Dryson EW, Ogden JA. Organic solvent induced chronic tox ic encephalopathy: extent of recovery, and associated factors, following cessation of exposure. Neurotoxicology 2000;21: 659-65.
24. Ekino S, Susa M, Ninomiya T, Imamura K, Kitamura T. Minamata disease revisited: an update on the acute and chronic manifestations of methyl mercury poisoning. J Neurol Sci 2007;262:131-44.
25. Matsumoto SC, Okajima T, Inayoshi S, Ueno H. Minamata disease demonstrated by computed tomography. Neuroradiology 1988;30:42-6.
26. Korogi Y, Takahashi M, Hirai T, Ikushima I, Kitajima M, Sugahara T, Shigematsu Y, Okajima T, Mukuno K. Representation of the visual field in the striate cortex: comparison of MR findings with visual field deficits in organic mercury poisoning (Minamata disease). AJNR Am J Neuroradiol 1997; 18:1127-30.
27. Itoh K, Korogi Y, Tomiguchi S, Takahashi M, Okajima T, Sato H. Cerebellar blood flow in methylmercury poisoning (Minamata disease). Neuroradiology 2001;43:279-84.
28. Takeuchi T. Pathology of Minamata disease. In: Study Group of Minamata Disease, editor. Minamata disease. Kumamoto (Japan): Kumamoto University; 1968. p. 141-228.
29. Geyer HL, Schaumburg HH, Herskovitz S. Methyl bromide intoxication causes reversible symmetric brainstem and cerebellar MRI lesions. Neurology 2005;64:1279-81.
30. De Haro L, Gastaut JL, Jouglard J, Renacco E. Central and peripheral neurotoxic effects of chronic methyl bromide intoxication. J Toxicol Clin Toxicol 1997;35:29-34.
31. Kim SH, Yoo CI, Kwon JH, Bae JH, Weon YC, Kim Y. A case of cerebellar dysfunction after acute organotin poisoning. Korean J Occup Environ Med 2009;21:289-92.
32. RODIER J. Manganese poisoning in Moroccan miners. Br J Ind Med 1955;12:21-35.
33. Huang CC, Chu NS, Lu CS, Chen RS, Calne DB. Long-term progression in chronic manganism: ten years of follow-up. Neurology 1998;50:698-700.
34. Fitsanakis VA, Au C, Erikson KM, Aschner M. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int 2006;48:426-33.
35. Lucchini R, Kim Y. Health effects of manganese. In: Vojtisek M, Prakash R, editors. Metals and neurotoxicity. Society for science and environment: Jalgaon (India); 2009. p. 119-47.
36. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994;44:1583-6.
37. Feldman RG. Occupational and environmental neurotoxicology. 1st ed. Philadelphia (PA): Lippincott-Raven Press; 1999. p. 168-88.
38. Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 1986; 70:273-8.
39. Kim Y. Neuroimaging in manganism. Neurotoxicology 2006; 27:369-72.
40. Kim Y, Kim KS, Yang JS, Park IJ, Kim E, Jin Y, Kwon KR, Chang KH, Kim JW, Park SH, Lim HS, Cheong HK, Shin YC, Park J, Moon Y. Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology 1999;20:901-7.
41. Newland MC, Ceckler TL, Kordower JH, Weiss B. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 1989;106:251-8.
42. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993;50:510-3.
43. Kim Y, Kim JW, Ito K, Lim HS, Cheong HK, Kim JY, Shin YC, Kim KS, Moon Y. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 1999;20:249-52.
44. Park J, Kim Y, Kim JW. High signal intensities on T1-weighted MRI in the spectrum of manganese symptomatology. In: Webster LR, editor. Neurotoxicity syndrome. New York (NY): Nova Biomedical Books; 2007. p. 249-60.
45. Zoni S, Albini E, Lucchini R. Neuropsychological testing for the assessment of manganese neurotoxicity: a review and a proposal. Am J Ind Med 2007;50:812-30.
46. Kim Y, Kim JM, Kim JW, Yoo CI, Lee CR, Lee JH, Kim HK, Yang SO, Chung HK, Lee DS, Jeon B. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Mov Disord 2002;17:568-75.
47. Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983;40:433-5.
48. Lee WK, Yu ZH, Lee CC. Delayed neurological sequelae after carbon monoxide poisoning. Aust N Z J Psychiatry 2008; 42:430.
49. Lassinger BK, Kwak C, Walford RL, Jankovic J. Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity? Mov Disord 2004;19:465-9.
50. Sohn YH, Jeong Y, Kim HS, Im JH, Kim JS. The brain lesion responsible for parkinsonism after carbon monoxide poisoning. Arch Neurol 2000;57:1214-8.
51. Ley CO, Gali FG. Parkinsonian syndrome after methanol intoxication. Eur Neurol 1983;22:405-9.
52. Huang CC. Carbon disulfide neurotoxicity: Taiwan experience. Acta Neurol Taiwan 2004;13:3-9.
53. Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 2002;23:621-33.
54. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide expo sure reproduces features of Parkinson's disease. Nat Neurosci 2000;3:1301-6.
55. Rosenow F, Herholz K, Lanfermann H, Weuthen G, Ebner R, Kessler J, Ghaemi M, Heiss WD. Neurological sequelae of cyanide intoxication-the patterns of clinical, magnetic resonance imaging, and positron emission tomography findings. Ann Neurol 1995;38:825-8.
56. Tolonen M. Vascular effects of carbon disulfide: a review. Scand J Work Environ Health 1975;1:63-77.
57. Lee EI, Kim SD, Kim HJ, Kim KJ, Yum YT. Carbon disulfide poisoning in Korea with social and historical background. J Occup Health 1996;38:155-61.
58. Choi JW, Jang SH. A review on the carbon disulfide poisoning experienced in Korean. Korean J Occup Environ Med 1991;3:11-20. Korean.
59. Huang CC, Chu CC, Chu NS, Wu TN. Carbon disulfide vasculopathy: a small vessel disease. Cerebrovasc Dis 2001;11: 245-50.
60. Chu CC, Huang CC, Chen RS, Shih TS. Polyneuropathy induced by carbon disulphide in viscose rayon workers. Occup Environ Med 1995;52:404-7.
61. Hernberg S, Partanen T, Nordman CH, Sumari P. Coronary heart disease among workers exposed to carbon disulphide. Br J Ind Med 1970;27:313-25.
62. Karai I, Sugimoto K, Goto S. A fluorescein angiographic study on carbon disulfide retinopathy among workers in viscose rayon factories. Int Arch Occup Environ Health 1983;53: 91-9.
63. Yamagata Y, Yuda A, Suzuki K, Nemoto T, Takahashi M, Tuchida H, Saito K, Kusunoki N. Carbon disulphide nephrosclerosis, with special reference to the similarity to diabetic glomerulosclerosis: Renal biopsy findings in 17 patients. J Jpn Diabetical Soc 1966;9:208-17. Japanese.
64. Chuang WL, Huang CC, Chen CJ, Hsieh YC, Kuo HC, Shih TS. Carbon disulfide encephalopathy: cerebral microangiopathy. Neurotoxicology 2007;28:387-93.
65. Miura T. Work and health in rayon and staple industry. In: Miura T, editor. History of work and health, Vol. 4. Kawasaki (Japan): Institute for Science of Labour; 1981. p. 203-36. Japanese.
66. Harada M. Gold and mercury. Tokyo (Japan): Kodansha; 2002. Japanese.
67. Park J, Hisanaga N, Kim Y. Transfer of occupational health problems from a developed to a developing country: lessons from the Japan-South Korea experience. Am J Ind Med 2009; 52:625-32.
68. Johnson FO, Atchison WD. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology 2009;30:761-5.
69. Kim EA, Kang SK. Occupational neurological disorders in Korea. J Korean Med Sci 2010;25(Suppl):S26-35.
70. McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, van Belle G. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 1997;145:1076-88.
71. Weisskopf MG, Morozova N, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, Ascherio A. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2009;80:558-61.
72. Feldman RG. Occupational neurology. Yale J Biol Med 1987; 60:179-86.
73. Anger WK, Cassitto MG. Individual-administered human behavioral test batteries to identify neurotoxic chemicals. Environ Res 1993;61:93-106.
74. Mergler D, Huel G, Bélanger S, Bowler RM, Truchon G, Drolet D, Ostiguy C. Surveillance of early neurotoxic dysfunction. Neurotoxicology 1996;17:803-12.
75. World Health Organization (WHO). Neurotoxicity risk assessment for human health: Principles and approaches; Environmental health criteria 223. Geneva (Switzerland): WHO; 2001.
76. Meyer-Baron M, Blaszkewicz M, Henke H, Knapp G, Muttray A, Schäper M, van Thriel C. The impact of solvent mixtures on neurobehavioral performance: conclusions from epidemiological data. Neurotoxicology 2008;29:349-60.
77. American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the threshold limit values and biological exposure indices. 7th ed. Cincinnati (OH): ACGIH; 2011.
78. Seppäläinen AM, Härkönen H. Neurophysiological findings among workers occupationally exposed to styrene. Scand J Work Environ Health 1976;2:140-6.
79. Seppäläinen AM. Neurophysiological approaches to the detection of early neurotoxicity in humans. Crit Rev Toxicol 1988;18:245-98.
80. Arezzo JC, Simson R, Brennan NE. Evoked potentials in the assessment of neurotoxicity in humans. Neurobehav Toxicol Teratol 1985;7:299-304.
81. Metrick SA, Brenner RP. Abnormal brainstem auditory evoked potentials in chronic paint sniffers. Ann Neurol 1982; 12:553-6.
82. Rosenberg NL, Spitz MC, Filley CM, Davis KA, Schaumburg HH. Central nervous system effects of chronic toluene abuse-clinical, brainstem evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 1988;10:489-95.
83. Lang CJ. The use of neuroimaging techniques for clinical detection of neurotoxicity: a review. Neurotoxicology 2000;21: 847-55.
84. Walker RC, Purnell GL, Jones-Jackson LB, Thomas KL, Brito JA, Ferris EJ. Introduction to PET imaging with emphasis on biomedical research. Neurotoxicology 2004;25:533-42.
85. Sutton D. Textbook of radiology and imaging. 7th ed. London (UK): Churchill Livingstone; 2002.
86. Kim Y, Yang SO. Neuroimaging in metal toxicity. In: Vojtisek M, Prakash R, editors. Metals and neurotoxicity. Jalgaon (India): Society for Science and Environment; 2009. p. 81-92.
87. Jensen PB, Nielsen P, Nielsen NO, Olivarius BD, Hansen JH. Chronic toxic encephalopathy following occupational exposure to organic solvents. The course after cessation of exposure illustrated by a neurophysiological follow-up study. Ugeskr Laeger 1984;146:1387-90.
88. Arora A, Neema M, Stankiewicz J, Guss ZD, Guss JG, Prockop L, Bakshi R. Neuroimaging of toxic and metabolic disorders. Semin Neurol 2008;28:495-510.
89. Hantson P, Duprez T. The value of morphological neuroimaging after acute exposure to toxic substances. Toxicol Rev 2006;25:87-98.
90. Rosen Y, Lenkinski RE. Recent advances in magnetic resonance neurospectroscopy. Neurotherapeutics 2007;4:330-45.
91. Ross AJ, Sachdev PS, Wen W, Brodaty H, Joscelyne A, Lorentz LM. Prediction of cognitive decline after stroke using proton magnetic resonance spectroscopy. J Neurol Sci 2006; 251:62-9.
92. Aydin K, Sencer S, Ogel K, Genchellac H, Demir T, Minareci O. Single-voxel proton MR spectroscopy in toluene abuse. Magn Reson Imaging 2003;21:777-85.
93. Meng XM, Zhu DM, Ruan DY, She JQ, Luo L. Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children. Neurology 2005;64:1644-7.
94. Trope I, Lopez-Villegas D, Cecil KM, Lenkinski RE. Exposure to lead appears to selectively alter metabolism of cortical gray matter. Pediatrics 2001;107:1437-42.
95. Weisskopf MG, Hu H, Mulkern RV, White R, Aro A, Oliveira S, Wright RO. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning. Environ Health Perspect 2004;112:620-5.
96. Weisskopf MG, Hu H, Sparrow D, Lenkinski RE, Wright RO. Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus. Environ Health Perspect 2007;115:519-23.
97. Guilarte TR, McGlothan JL, Degaonkar M, Chen MK, Barker PB, Syversen T, Schneider JS. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci 2006;94:351-8.
98. Kim EA, Cheong HK, Choi DS, Sakong J, Ryoo JW, Park I, Kang DM. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings. Neurotoxicology 2007;28:276-83.
99. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31.
100. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 1994;241:354-71.
101. Chang Y, Woo ST, Lee JJ, Song HJ, Lee HJ, Yoo DS, Kim SH, Lee H, Kwon YJ, Ahn HJ, Ahn JH, Park SJ, Weon YC, Chung IS, Jeong KS, Kim Y. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy. Neurotoxicology 2009;30:950-7.
102. Dydak U, Jiang YM, Long LL, Zhu H, Chen J, Li WM, Edden RA, Hu S, Fu X, Long Z, Mo XA, Meier D, Harezlak J, Aschner M, Murdoch JB, Zheng W. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect 2011;119:219-24.
103. Song AW, Huettel SA, McCarthy G. Functional neuroimaging: Basic principles of functional MRI. In: Cabeza R, Kingstone A, editors. Handbook of functional neuroimaging of cognition. 2nd ed. Cambridge (MA): The MIT Press; 2006. p. 21-52.
104. Chang Y, Song HJ, Lee JJ, Seo JH, Kim JH, Lee HJ, Kim HJ, Kim Y, Ahn JH, Park SJ, Kwon JH, Jeong KS, Jung DK. Neuroplastic changes within the brains of manganese-exposed welders: recruiting additional neural resources for successful motor performance. Occup Environ Med 2010;67:809-15.
105. Chang Y, Lee JJ, Seo JH, Song HJ, Kim JH, Bae SJ, Ahn JH, Park SJ, Jeong KS, Kwon YJ, Kim SH, Kim Y. Altered working memory process in the manganese-exposed brain. Neuroimage 2010;53:1279-85.
106. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed 2002;15: 435-55.
107. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534-46.
108. Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS, Wendland MF, Tsuruda J, Norman D. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176:439-45.
109. Kinoshita Y, Ohnishi A, Kohshi K, Yokota A. Apparent diffusion coefficient on rat brain and nerves intoxicated with methylmercury. Environ Res 1999;80:348-54.
110. McKinney AM, Filice RW, Teksam M, Casey S, Truwit C, Clark HB, Woon C, Liu HY. Diffusion abnormalities of the globi pallidi in manganese neurotoxicity. Neuroradiology 2004;46:291-5.
111. Peters AS, Schwarze B, Tomandl B, Probst-Cousin S, Lang CJ, Hilz MJ. Bilateral striatal hyperintensities on diffusion weighted MRI in acute methanol poisoning. Eur J Neurol 2007;14:e1-2.
112. Sener RN. Acute carbon monoxide poisoning: diffusion MR imaging findings. AJNR Am J Neuroradiol 2003;24:1475-7.
113. Lo CP, Chen SY, Chou MC, Wang CY, Lee KW, Hsueh CJ, Chen CY, Huang KL, Huang GS. Diffusion-tensor MR imaging for evaluation of the efficacy of hyperbaric oxygen therapy in patients with delayed neuropsychiatric syndrome caused by carbon monoxide inhalation. Eur J Neurol 2007;14:777-82.
114. Kim Y, Jeong KS, Song HJ, Lee JJ, Seo JH, Kim GC, Lee HJ, Kim HJ, Ahn JH, Park SJ, Kim SH, Kwon YJ, Chang Y. Altered white matter microstructural integrity revealed by voxel-wise analysis of diffusion tensor imaging in welders with manganese exposure. Neurotoxicology 2011;32:100-9.
115. Sheehan W, Thurber S. SPECT and neuropsychological measures of lithium toxicity. Aust N Z J Psychiatry 2006;40:277.
116. Huang CC, Weng YH, Lu CS, Chu NS, Yen TC. Dopamine transporter binding in chronic manganese intoxication. J Neurol 2003;250:1335-9.
117. Kim J, Kim JM, Kim YK, Shin JW, Choi SH, Kim SE, Kim Y. Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism. Ind Health 2007;45:497-500.
118. Cherry SR, Gambhir SS. Use of positron emission tomography in animal research. ILAR J 2001;42:219-32.
119. Zijlstra JM, Hoekstra OS, Raijmakers PG, Comans EF, van der Hoeven JJ, Teule GJ, Jonkhoff AR, van Tinteren H, Lammertsma AA, Huijgens PC. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. Br J Haematol 2003;123:454-62.
120. Pogge A, Slikker W Jr. Neuroimaging: new approaches for neurotoxicology. Neurotoxicology 2004;25:525-31.
121. Wolters EC, Huang CC, Clark C, Peppard RF, Okada J, Chu NS, Adam MJ, Ruth TJ, Li D, Calne DB. Positron emission tomography in manganese intoxication. Ann Neurol 1989;26: 647-51.
122. Eriksson H, Tedroff J, Thuomas KA, Aquilonius SM, Hartvig P, Fasth KJ, Bjurling P, Långström B, Hedström KG, Heilbronn E. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 1992;66:403-7.
123. Shinotoh H, Snow BJ, Chu NS, Huang CC, Lu CS, Lee C, Takahashi H, Calne DB. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 1997; 48:1053-6.
124. Brooks DJ, Salmon EP, Mathias CJ, Quinn N, Leenders KL, Bannister R, Marsden CD, Frackowiak RS. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 1990;113:1539-52.
125. Schneider JS, Tobe EH, Mozley PD Jr, Barniskis L, Lidsky TI. Persistent cognitive and motor deficits following acute hydrogen sulphide poisoning. Occup Med (Lond) 1998;48:255-60.